Integrated proteomics and metabolomics analysis of lumbar in a rat model of osteoporosis treated with Gushukang capsules.

Abstract

BACKGROUND:

Gushukang (GSK) capsules are a Chinese patented medicine that is widely used in clinics for the treatment of osteoporosis (OP). Animal experiments have revealed that the bone mineral density of osteoporotic rats increase after treatment with GSK capsules. However, the specific mechanism and target of GSK in the treatment of osteoporosis are unclear. Further studies are needed.

METHODS:

Metabolomics (GC/MS) and proteomics (TMT-LC-MC/MC) with bioinformatics (KEGG pathway enrichment), correlation analysis (Pearson correlation matrix), and joint pathway analysis (MetaboAnalyst) were employed to determine the underlying mechanisms of GSK. The differential expression proteins were verified by WB experiment.

RESULTS:

The regulation of proteins, i.e., Cant1, Gstz1, Aldh3b1, Bid, and Slc1a3, in the common metabolic pathway of differential proteins and metabolites between GSK/OP and OP/SHAM was corrected in the GSK group. The regulation of 12 metabolites (tyramine, thymidine, deoxycytidine, cytosine, L-Aspartate, etc.) were differential in the common enrichment metabolic pathway between GSK /OP and OP/SHAM. Differential proteins and metabolites jointly regulate 11 metabolic pathways, such as purine metabolism, pyrimidine metabolism, histidine metabolism, beta-alanine metabolism, and so on.

CONCLUSION:

GSK may protect bone metabolism in osteoporotic rats by affecting nucleotide metabolism, amino acid metabolism, and the immune system.

• Authors: Ruohui Lin, Bingying Xie, Lihua Xie, Jirong Ge, Shengqiang Li
• Journal: BMC complementary medicine and therapies (BMC Complement Med Ther) Vol. 22 Issue 1 Pg. 333 (Dec 15 2022) ISSN: 2662-7671 [Electronic] England
• PMID: 36522793 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Glutathione Transferase
• Gstz1 protein, rat
• gushukang

Topics

• Animals
• Rats
• Glutathione Transferase
• Metabolomics
• Osteoporosis (drug therapy)
• Proteomics